|
Eli Lilly and Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1038
|
$962B |
15.1x |
33.3x |
|
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$219
|
$554B |
5.9x |
15.5x |
|
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$214
|
$442B |
7.3x |
16.9x |
|
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 350
|
$376B |
4.8x |
12.2x |
|
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£141
|
$318B |
5.4x |
15.6x |
|
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 116
|
$300B |
5.5x |
13.3x |
|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$109
|
$293B |
4.5x |
9.8x |
|
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 389
|
$281B |
5.8x |
12.0x |
|
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$330
|
$223B |
6.1x |
12.6x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$26
|
$192B |
3.1x |
7.7x |
|
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$125
|
$173B |
5.9x |
10.8x |
|
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$55
|
$147B |
3.1x |
7.9x |
|
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€81
|
$122B |
2.3x |
7.7x |
|
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£18
|
$118B |
2.7x |
8.0x |
|
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$441
|
$108B |
9.0x |
19.9x |
|
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€42
|
$85.7B |
1.6x |
7.7x |
|
Chugai Pharmaceutical Co
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 8252
|
$81.0B |
10.2x |
20.0x |
|
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€130
|
$76.7B |
3.1x |
10.8x |
|
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 5073
|
$76.0B |
2.6x |
9.8x |
|
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$733
|
$71.3B |
5.0x |
14.2x |
|
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$125
|
$60.1B |
6.4x |
14.6x |
|
Haleon
|
United Kingdom of Great Britain and Northern Ireland |
Health & Beauty,
Drug Development & Therapeutics
|
£4
|
$54.1B |
3.6x |
14.5x |
|
Jiangsu Hengrui Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 62
|
$53.2B |
11.3x |
37.3x |
|
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 102
|
$51.6B |
3.0x |
10.1x |
|
Galderma Group
|
Switzerland |
Health & Beauty,
Drug Development & Therapeutics
|
CHF 159
|
$49.2B |
9.5x |
41.4x |
|
argenx
|
Belgium |
Drug Development & Therapeutics
|
€694
|
$46.2B |
11.0x |
38.8x |
|
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$359
|
$46.0B |
12.3x |
65.7x |
|
Fresenius
|
Germany |
Hospitals & Clinics,
Medical Supplies,
Drug Development & Therapeutics
|
€50
|
$45.6B |
1.7x |
10.3x |
|
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1669
|
$41.9B |
6.7x |
23.5x |
|
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 62
|
$37.8B |
3.4x |
15.9x |
|
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3309
|
$36.6B |
2.8x |
13.8x |
|
BeOne Medicines
|
Hong Kong |
Drug Development & Therapeutics
|
HKD 214
|
$36.5B |
6.9x |
69.4x |
|
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$161
|
$33.3B |
64.8x |
-29.8x |
|
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 43
|
$29.0B |
13.7x |
35.7x |
|
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2244
|
$28.5B |
2.2x |
9.4x |
|
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 9015
|
$28.5B |
1.8x |
7.6x |
|
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$13
|
$28.4B |
2.0x |
6.9x |
|
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$164
|
$26.8B |
2.7x |
8.8x |
|
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 10
|
$22.4B |
2.2x |
6.2x |
|
Revolution Medicines
|
United States of America |
Drug Development & Therapeutics
|
$120
|
$21.5B |
5587.1x |
-19.0x |
|
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 90
|
$18.9B |
9.7x |
95.9x |
|
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 315
|
$18.3B |
57.7x |
N/A |
|
Divi's Laboratories
|
India |
Contract Research & Manufacturing,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 6236
|
$18.1B |
15.7x |
48.2x |
|
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$106
|
$18.0B |
3.6x |
11.3x |
|
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 2185
|
$17.7B |
4.9x |
12.7x |
|
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€10
|
$17.3B |
2.0x |
8.1x |
|
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$465
|
$16.9B |
5.3x |
10.1x |
|
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$76
|
$15.9B |
32.2x |
-34.7x |
|
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$25
|
$15.7B |
3.4x |
17.7x |
|
Torrent Pharmaceuticals
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 4018
|
$15.3B |
10.9x |
33.2x |
|
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 7
|
$14.8B |
3.1x |
11.5x |
|
Zhangzhou Pientzehuang
|
China |
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
CNY 169
|
$14.5B |
10.2x |
32.1x |
|
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 121
|
$14.0B |
29.4x |
-1386.8x |
|
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€48
|
$13.8B |
4.5x |
12.1x |
|
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 332
|
$13.8B |
4.4x |
11.6x |
|
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$169
|
$13.7B |
3.2x |
14.5x |
|
Regencell Bioscience
|
United States of America |
Drug Development & Therapeutics
|
$27
|
$13.6B |
N/A |
N/A |
|
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 474
|
$13.6B |
48.4x |
-293.0x |
|
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 26
|
$13.2B |
2.3x |
13.9x |
|
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 10
|
$13.1B |
3.3x |
13.1x |
|
Ascendis Pharma
|
Germany |
Drug Development & Therapeutics
|
€177
|
$13.0B |
N/A |
N/A |
|
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$42
|
$12.6B |
6.6x |
-3.9x |
|
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$132
|
$12.5B |
4.4x |
19.0x |
|
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$17
|
$12.5B |
N/A |
-12.1x |
|
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€135
|
$12.3B |
2.8x |
7.3x |
|
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2862
|
$12.0B |
3.9x |
9.6x |
|
Roivant Sciences
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$23
|
$11.8B |
643.0x |
-10.5x |
|
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$11.7B |
0.3x |
5.0x |
|
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€70
|
$11.7B |
5.3x |
14.3x |
|
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$76
|
$11.6B |
13.0x |
-31.4x |
|
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1398
|
$11.4B |
3.6x |
14.8x |
|
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 2176
|
$11.0B |
3.9x |
15.3x |
|
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$44
|
$11.0B |
4.7x |
11.7x |
|
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$109
|
$10.8B |
3.5x |
-8.7x |
|
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1176
|
$10.8B |
2.9x |
11.6x |
|
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$502
|
$10.6B |
11.2x |
-36.1x |
|
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2176
|
$10.5B |
6.8x |
27.1x |
|
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$10.4B |
1.7x |
5.4x |
|
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 868
|
$9.9B |
3.6x |
12.8x |
|
BioMarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$55
|
$9.6B |
3.0x |
13.0x |
|
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 39
|
$9.4B |
1.5x |
11.8x |
|
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$71
|
$9.2B |
6.9x |
10.5x |
|
Avidity Biosciences
|
United States of America |
Drug Development & Therapeutics
|
$73
|
$9.1B |
467.9x |
-13.5x |
|
Axsome Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$177
|
$8.8B |
14.0x |
-53.9x |
|
Haisco Pharmaceutical
|
China |
Drug Development & Therapeutics
|
CNY 54
|
$8.7B |
13.7x |
79.0x |
|
Abivax
|
France |
Drug Development & Therapeutics,
Biopharmaceuticals
|
€102
|
$8.7B |
861.2x |
-36.5x |
|
Praxis Precision Medicines
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$317
|
$8.5B |
28562.2x |
-28.7x |
|
Lundbeck
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 45
|
$8.4B |
N/A |
N/A |
|
Arrowhead Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$64
|
$8.3B |
11.5x |
208.2x |
|
Sumitomo Pharma
|
Japan |
Drug Development & Therapeutics
|
JPY 2750
|
$8.3B |
3.0x |
11.2x |
|
Caliway Biopharmaceuticals
|
Taiwan |
Drug Development & Therapeutics
|
TWD 170
|
$8.2B |
6776.2x |
-294.6x |
|
Salubris Pharmaceuticals
|
China |
Drug Development & Therapeutics,
Medical Devices
|
CNY 52
|
$8.2B |
12.6x |
52.0x |
|
Cytokinetics
|
United States of America |
Drug Development & Therapeutics
|
$63
|
$7.9B |
97.9x |
-13.0x |
|
Eisai Co.
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4515
|
$7.7B |
1.5x |
12.3x |
|
Krystal Biotech
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$285
|
$7.5B |
19.5x |
44.9x |
|
ABL Bio
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 197500
|
$7.5B |
94.9x |
16620.8x |
|
Alkem Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 5837
|
$7.5B |
4.7x |
23.7x |
|
Aurobindo Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1173
|
$7.4B |
2.0x |
9.9x |
|
Krka
|
Slovenia |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€221
|
$7.2B |
3.0x |
9.1x |
|
Nuvalent
|
United States of America |
Drug Development & Therapeutics
|
$104
|
$7.2B |
N/A |
-17.4x |